Helus Pharma Inc.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Helus Pharma Inc. is publicly traded on NASDAQ under the ticker HELP.
Helus Pharma is a clinical-stage pharmaceutical company developing proprietary serotonergic agonists for mental health conditions. Its pipeline includes HLP003, in Phase 3 development for adjunctive treatment of major depressive disorder, and HLP004, in Phase 2 development for generalized anxiety disorder.
Can you invest in Helus Pharma Inc.?
Yes. Helus Pharma Inc. trades publicly on NASDAQ as HELP.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Helus Pharma Inc.
Detailed equity research is provided by MarketSnap.